The show is based on the Goosebumps books by author R.L. Stine, and Schwimmer plays Anthony, a single father of two teens, ...

SACRAMENTO, Calif. — Up and down, the two high-octane offenses went. The Memphis Grizzlies and Sacramento Kings combined for 202 points through three quarters in a battle of fast and explosive ...

This highlights the Company's ability to diversify its business and expand into new markets Following these recent accomplishments, we believe we are better positioned to continue to expand our reach ...

Notes to Exhibit 7: (a) Pallas Green MRE is owned by Glencore (see Glencore's Resources and Reserves Report dated December 31, 2023); (b) Stonepark MRE: see the 'NI 43-101 Independent Report on the ...

BOSTON — Hockey was not fun for Matt Poitras. The second-year pro was parked in a four-game pointless streak. His coach was on him. On Nov. 9, Poitras earned only 11:08 of ice time in a 3-2 ...

Here's what to know about his latest appointments. The final countdown: Matt Meyer's Inauguration Day to include outdoor swearing-in ceremony, reception and ball Anders Gordon has worked in various ...

If there's one thing the Chicago Bears are sure to do in their head coaching search, it's bring in someone who thinks differently than Matt Eberflus. Eberflus was fired in November midway through ...

At the Carrickittle West prospect, spanning the Stonepark and PG West Projects, drilling has been completed according to plan with results expected mid-late Q1 2025 "We are excited to start our ...

– Niktimvo™ (axatilimab-csfr) approved by U.S. FDA for treatment of chronic GVHD after failure of at least two prior lines of systemic therapy in adult and pediatric patients weighing at least 40 kg – ...

Is he is, or is he ain't for real? Matt Rempe, that is; the Ranger who is in the midst of a crusade to be taken seriously as a legitimate major leaguer. He'll get a chance tonight in Denver ...

Completed enrollment in Phase 2 BESTOW trial assessing tegoprubart in kidney transplantation four months ahead of schedule; on track to report topline results in fourth quarter of 2025 Presented ...

Initial data from 12-month evaluable NMIBC patients in ADVANCED-2 trial expected in mid-2025; Results from a futility analysis of approximately 25 six-month evaluable BCG-Unresponsive patients ...